Fabio Petrocca

3 ta ish

Dana-Farber Cancer Institute

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

3. A microRNA expression signature of human solid tumors defines cancer gene targets

   Stefano Volinia, George A. Calin, Chang‐Gong Liu +15

   MaqolaOAOchiq kirish20065 iqtibos

   ABIABI:AkademIndex/2026.other.214068